LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
- Your personalised programme is built around medical care, not willpower.
- No generic diets. No guesswork.
- Just science-backed results and expert support.
Find out if you’re eligible
Zepbound (tirzepatide) is administered once weekly as a subcutaneous injection for chronic weight management in adults. This dual GIP and GLP-1 receptor agonist features a five-day half-life that supports convenient weekly dosing, reaching steady-state concentrations after approximately four weeks. The FDA-approved regimen begins with 2.5 mg once weekly, gradually increasing over several months to optimize effectiveness while minimizing gastrointestinal side effects. Patients inject on the same day each week using a prefilled pen, with flexible timing throughout the day. Understanding proper dosing schedules, administration techniques, and what to do if you miss a dose is essential for successful weight management with Zepbound.
Quick Answer: Zepbound (tirzepatide) is administered once weekly as a subcutaneous injection for chronic weight management in adults.
Yes, Zepbound (tirzepatide) is administered once weekly as a subcutaneous injection for chronic weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with at least one weight-related condition. This medication should be used in conjunction with a reduced-calorie diet and increased physical activity.
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Its pharmacokinetic profile supports weekly dosing, with a half-life of approximately five days. After subcutaneous injection, the medication is gradually absorbed and reaches steady-state concentrations after about four weeks of consistent weekly dosing. This extended half-life allows the drug to remain active in your system between doses.
The FDA-approved dosing regimen begins with a lower starting dose that is gradually increased over several months. This titration schedule helps minimize gastrointestinal side effects while allowing your body to adjust to the medication. The standard starting dose is 2.5 mg once weekly for four weeks, which serves primarily as a tolerance-building phase rather than a therapeutic dose for weight loss.
Patients should administer their weekly injection on the same day each week to maintain consistent drug levels. The specific time of day is flexible and can be adjusted based on your schedule and when you experience the fewest side effects. Many patients find that establishing a regular routine—such as injecting every Sunday morning—helps ensure adherence to the weekly schedule.
Important safety note: Zepbound has a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
Find out if you’re eligible
Proper administration technique is essential for ensuring Zepbound's effectiveness and minimizing injection site reactions. Zepbound comes in a single-dose prefilled pen that is designed for subcutaneous injection. For self-injection, use the abdomen or thigh. The upper arm may be used only if a caregiver administers the injection. Rotate injection sites weekly to reduce the risk of lipodystrophy or localized reactions.
Before each injection, inspect the medication through the pen's viewing window. The solution should be clear and colorless to slightly yellow. Do not use Zepbound if the liquid appears cloudy, discolored, or contains particles. Remove the pen from the refrigerator 30 minutes before injection to allow it to reach room temperature, which can make the injection more comfortable. Never warm the pen using a microwave, hot water, or direct heat sources.
Step-by-step administration process:
Wash your hands thoroughly with soap and water
Clean the injection site with an alcohol swab and allow it to dry completely
Remove the pen cap and check that the solution looks clear
Place the clear base flat against your skin at the injection site
Unlock the pen by turning the lock ring
Press and hold the injection button until you hear a second click and see the yellow indicator has stopped moving (approximately 10 seconds)
Remove the pen from your skin and dispose of it in an FDA-cleared sharps container
Do not share your Zepbound pen with others, even if the needle is changed, as this poses a risk of infection transmission. Store unused pens in the refrigerator at 36°F to 46°F (2°C to 8°C) and protect them from light. If needed, unused pens may be kept at room temperature (up to 86°F or 30°C) for up to 21 days. Never freeze Zepbound, and discard any medication that has been frozen. When traveling with Zepbound, avoid placing pens directly against ice packs to prevent freezing.
Missing a dose of Zepbound can disrupt your treatment schedule and potentially affect your weight management progress. If you miss your scheduled weekly dose, the recommended action depends on how much time has passed since your missed injection.
According to FDA prescribing information, if you remember within four days (96 hours) of your missed dose, take the injection as soon as possible. Then resume your regular weekly schedule on your originally planned day. For example, if you typically inject on Mondays but forget until Wednesday, take your dose on Wednesday and continue with your regular Monday schedule the following week.
However, if more than four days have passed since your missed dose, skip the missed injection entirely and take your next dose on your regularly scheduled day. Do not take two doses within three days (72 hours) of each other, as this may increase the risk of gastrointestinal side effects including nausea, vomiting, and diarrhea.
Missing doses may potentially lead to:
Changes in appetite and satiety
Temporary weight management challenges
Possible gastrointestinal effects when resuming treatment
Delayed achievement of weight loss goals
To minimize missed doses, consider setting a weekly reminder on your phone, using a medication tracking app, or coordinating your injection with a regular weekly activity. If you frequently miss doses or struggle with adherence, discuss this with your healthcare provider. They may be able to help you identify barriers to consistent use or adjust your treatment plan accordingly. Consistent weekly dosing is important for achieving and maintaining optimal weight management results with Zepbound.
Zepbound treatment follows a structured dose escalation protocol designed to optimize weight loss while minimizing adverse effects. The medication is not prescribed at a single fixed dose but rather increased gradually over several months based on individual tolerance and response to treatment.
The FDA-approved titration schedule begins with 2.5 mg once weekly for four weeks. This initial dose primarily serves to build tolerance to the medication's gastrointestinal effects. After four weeks, the dose is increased to 5 mg once weekly, which represents the first maintenance dose for weight management. If additional weight loss is needed and the medication is well-tolerated, your healthcare provider may increase the dose in 2.5 mg increments, no more frequently than every 4 weeks.
The available maintenance doses include:
5 mg once weekly
7.5 mg once weekly
10 mg once weekly
12.5 mg once weekly
15 mg once weekly (maximum approved dose)
Dose escalation decisions should be individualized based on several factors, including weight loss response, tolerability of gastrointestinal side effects, and overall treatment goals. Clinical trials demonstrated that higher doses generally produced greater weight loss, but they also carried an increased risk of adverse effects. Your healthcare provider will assess your progress at regular intervals and determine whether dose increases are appropriate.
If you experience intolerable side effects at any dose level, your provider may recommend delaying the next scheduled increase or even reducing to the previous dose temporarily. This flexible approach allows for personalized treatment while maintaining safety. If you take insulin or sulfonylureas for diabetes, dose adjustments of these medications may be necessary during Zepbound titration to reduce the risk of hypoglycemia.
Never adjust your Zepbound dose independently without consulting your healthcare provider, as improper dosing can compromise both efficacy and safety. Regular follow-up appointments are essential for monitoring your response to treatment, assessing for adverse effects, and making appropriate dose adjustments to achieve your weight management goals.
Can I change my weekly injection day? Yes, you can change your scheduled injection day if needed, provided there are at least three days (72 hours) between doses. For example, if you normally inject on Mondays but need to switch to Thursdays, you can take your next dose on Thursday (ensuring at least 72 hours have passed since your Monday dose), then continue weekly on Thursdays thereafter.
What if I need to travel across time zones? When traveling, maintain your weekly schedule based on your home time zone or the time zone where you'll spend most of your time. The specific time of day is less critical than maintaining the seven-day interval between doses. Zepbound pens may be kept at room temperature (≤86°F/30°C) for up to 21 days. When traveling, keep pens in your carry-on luggage, protect from light, and avoid freezing. If using an insulated case with ice packs, prevent direct contact between pens and ice packs.
Can I take Zepbound with other medications? Zepbound can interact with certain medications, particularly those that affect blood sugar levels or are taken orally. The medication slows gastric emptying, which may affect the absorption of oral medications. Inform your healthcare provider about all medications you take, including insulin, sulfonylureas, and oral contraceptives. If you use oral contraceptives, you should use a non-oral method or add a barrier method for 4 weeks after starting Zepbound and for 4 weeks after each dose increase. Do not use Zepbound with other GLP-1 receptor agonists or with Mounjaro (which contains the same active ingredient, tirzepatide).
Is it normal to experience injection site reactions? Mild injection site reactions—including redness, itching, or slight swelling—are common and typically resolve within a few days. Rotating injection sites weekly helps minimize these reactions. However, contact your healthcare provider if you develop severe pain, significant swelling, or signs of infection such as warmth, increasing redness, or drainage at the injection site.
What should I do if I accidentally inject the wrong dose? If you accidentally inject a higher dose than prescribed, contact your healthcare provider or seek medical attention immediately, especially if you develop severe nausea, vomiting, or abdominal pain. Monitor for signs of hypoglycemia if you have diabetes. Do not attempt to compensate by skipping future doses without medical guidance.
What are important safety considerations? Contact your healthcare provider immediately if you experience symptoms of pancreatitis (severe abdominal pain that may radiate to your back, with or without vomiting), gallbladder problems (pain in your upper stomach, fever, yellowing of skin/eyes), or severe allergic reactions. Zepbound is not recommended during pregnancy or breastfeeding. Discuss contraception planning with your healthcare provider if you're of childbearing potential.
Yes, you can change your scheduled injection day provided there are at least three days (72 hours) between doses. After taking your next dose on the new day, continue weekly injections on that day thereafter.
If you remember within four days (96 hours), take the injection as soon as possible and resume your regular schedule. If more than four days have passed, skip the missed dose and take your next injection on your regularly scheduled day.
Zepbound starts at 2.5 mg once weekly for four weeks, then increases to 5 mg. Your healthcare provider may increase the dose in 2.5 mg increments every four weeks based on tolerance and response, up to a maximum of 15 mg once weekly.
All medical content on this blog is created using reputable, evidence-based sources and is regularly reviewed for accuracy and relevance. While we strive to keep our content current with the latest research and clinical guidelines, it is intended for general informational purposes only.
This content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider with any medical questions or concerns. Use of this information is at your own risk, and we are not liable for any outcomes resulting from its use.
